Literature DB >> 15770999

Parkinson's disease: from causes to mechanisms.

Olga Corti1, Cornelia Hampe, Frédéric Darios, Pablo Ibanez, Merle Ruberg, Alexis Brice.   

Abstract

Parkinson's disease (PD) is a common age-related, progressive neurodegenerative disease of unknown etiology. Environmental factors have long been suspected to participate in the pathogenesis of PD due to the existence of neurotoxins that preferentially damage the dopaminergic nigrostriatal pathway. In the past few years, novel insights into the degenerative process have been provided by the discovery of genes responsible for rare monogenic parkinsonian syndromes. Compelling evidence is accumulating, suggesting that the products of several of these genes can interact with environmental toxins and intervene in molecular pathways controlling the functional integrity of mitochondria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770999     DOI: 10.1016/j.crvi.2004.10.009

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  14 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 2.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

3.  Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation.

Authors:  Ismail O Ishola; A A Akinyede; T P Adeluwa; C Micah
Journal:  Metab Brain Dis       Date:  2018-06-01       Impact factor: 3.584

Review 4.  Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network.

Authors:  Atsushi Tanaka
Journal:  FEBS Lett       Date:  2010-02-25       Impact factor: 4.124

5.  Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.

Authors:  Thomas Haggerty; Joel Credle; Olga Rodriguez; Jonathan Wills; Adam W Oaks; Eliezer Masliah; Anita Sidhu
Journal:  Eur J Neurosci       Date:  2011-04-01       Impact factor: 3.386

Review 6.  The PINK1/Parkin pathway: a mitochondrial quality control system?

Authors:  Alexander J Whitworth; Leo J Pallanck
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

7.  Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.

Authors:  Mallika Somayajulu-Niţu; Jagdeep K Sandhu; Jerome Cohen; Marianna Sikorska; T S Sridhar; Anca Matei; Henryk Borowy-Borowski; Siyaram Pandey
Journal:  BMC Neurosci       Date:  2009-07-27       Impact factor: 3.288

8.  Parkinson's disease: is it a toxic syndrome?

Authors:  Seham A Gad Elhak; Abdel Aziz A Ghanem; Hassan Abdelghaffar; Sahar El Dakroury; Mohamed M Salama
Journal:  Neurol Res Int       Date:  2010-09-05

9.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

Review 10.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.